Related Experiment Video
Updated: May 29, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
CORE-MD clinical risk score for regulatory evaluation of artificial intelligence-based medical device software
Frank E Rademakers1, Elisabetta Biasin2, Nico Bruining3
1Emeritus Professor of Cardiology, KU Leuven, Leuven, Belgium. frank.rademakers@kuleuven.be.
Abstract:
The European CORE-MD consortium (Coordinating Research and Evidence for Medical Devices) proposes a score for medical devices incorporating artificial intelligence or machine learning algorithms. Its domains are summarised as valid clinical association, technical performance, and clinical performance. High scores indicate that extensive clinical investigations should be undertaken before regulatory approval, whereas lower scores indicate devices for which less pre-market clinical evaluation may be balanced by more post-market evidence.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Standards of Care II
Standards of Care I

